International Clinical Trial: Feasibility of an Exercise Prehabilitation Program for adults with lymphoma planned to receive Chimeric Antigen Receptor (CAR) T-cell therapy (CAR-T Therapy)

Posted On: 2026-04-17

Health & Lifestyle Health Daily Digest Online News

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000478314) titled 'Feasibility of an Exercise Prehabilitation Program for adults with lymphoma planned to receive Chimeric Antigen Receptor (CAR) T-cell therapy (CAR-T Therapy)' on April 17.

Study Type: Interventional

Study Design: Purpose: Prevention Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group

Primary Sponsor: Baker Heart and Diabetes Institute

Condition: Haematological Cancer Lymphoma Lymphoma (non Hodgkin's lymphoma) Haematological Cancer Lymphoma Lymphoma (non Hodgkin's lymphoma) Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

Intervention: The exerci...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

International Clinical Trial: Feasibility of an Exercise Prehabilitation Program for adults with lymphoma planned to receive Chimeric Antigen Receptor (CAR) T-cell therapy (CAR-T Therapy)